Table 3.

Multivariate regression analysis of predictors of outcome on Likert scale (excluding resolution) (column A) and resolution (column B) of any mood disorder regardless of attribution.

Predictors		A: Analysis of Likert scale outcome (excluding resolution)				B: Analysis of time to resolution
		Est.	95% CI		P	HR	95% CI		P
Gender	Female	0.20	−0.26	0.66	0.3985
Age at SLE diagnosis						0.805	0.637	1.019	0.0711
Location	US	−0.39	−1.64	0.85	0.0003	0.565	0.211	1.518	0.0125
	Mexico	0.52	−0.82	1.85		0.793	0.288	2.187
	Europe	0.73	−0.55	2.01		0.551	0.203	1.496
	Canada	0.33	−0.95	1.62		1.160	0.438	3.078
	Asia	0				1
Anti-depressant		0.51	0.12	0.90	0.0096
Immunosuppressive		0.55	0.20	0.91	0.0031
Any ongoing NP events in central/peripheral clusters by attribution*	Central, SLE attributed	−0.39	−0.83	0.04	0.0294	0.693	0.424	1.133	0.0183
	Central, non-SLE attributed	−0.52	−0.93	−0.12		0.595	0.394	0.898
	Peripheral, SLE attributed	0.26	−0.94	1.46		1.540	0.728	3.258
	Peripheral, non-SLE attributed	−1.01	−2.02	−0.01		Not estimable
	No NP events	0				1
Time since mood disorder onset	5+ years	−0.30	−0.74	0.14	0.3168
	4–5 years	0.05	−0.40	0.50
	2–3 years	0.10	−0.26	0.45
	<=1 year	0	0	0

^*Central, SLE attributed: patients with one or more ongoing central SLE attributed events at current visit

Central, non-SLE attributed: patients with one or more ongoing central non-SLE attributed events, but no ongoing central SLE-attributed events

Peripheral, SLE attributed: Patients with ongoing peripheral events only, of which one or more were SLE-attributed

Peripheral, non-SLE attributed: Patients with ongoing peripheral non-SLE attributed events only

No NP: patients without any ongoing NP events at current visit